About us
Profile
Strategy
Business
Business fields
Markets & brands
Sustainability
History
Commitment at all levels: Our sustainability ambition of a “Healthier life” guides our daily actions.
Read more
Investor Relations
Investor hub
Newsroom
Financial publications
Investment highlights
Corporate governance
Governance principles
Board of Directors
Executive Board
General Meeting
Financial calendar
Share
Share information
Analysts & consensus
Shareholder structure & share count
Bonds
Always up to date in our investor hub – the one-stop destination for all Group IR topics.
Learn more
News
Newsroom
News service
Press materials
DocMorris launches approx. CHF 200 million Convertible Bonds due 2029
Read more
Careers
Jobs
Areas of work
Locations
Culture
Diversity & inclusion
Leadership
Join the e-Health pioneers.
Learn more
News
DocMorris launches approx. CHF 200 million Convertible Bonds due 2029
9
Read more
Read more
17 Apr 2024
Ad hoc news
DocMorris launches approx. CHF 200 million Convertible Bonds due 2029
Read more
Read more
17 Apr 2024
News
Simple, fast and secure: Redeem e-prescriptions directly with your health card at DocMorris now
Read more
Read more
16 Apr 2024
News
DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market
Read more
Read more
10 Apr 2024
Ad hoc news
DocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card
Read more
Read more
21 Mar 2024
Ad hoc news
DocMorris AG: Significant earnings improvement in 2023; e-prescription is standard in Germany
Read more
Read more
15 Feb 2024
News
TeleClinic and ADAC: Partnership expands access to digital healthcare
Read more
Read more
08 Feb 2024
Stories
People
Technology
Digital Pioneers: IT vocational training at DocMorris
Read more
Read more
01 Feb 2024
News
Dorit Posdorf takes over marketing at DocMorris Germany
Read more
Read more
31 Jan 2024
News
Change in the management of TeleClinic
Read more
Search:
allform
All years
2024
2023
2022
2021
2020
2019
2018
2017
All news
Inside Information (AD-HOC Release)
Corporate News
DGAP-News
Aktuelle News
Press Release
All news
All news
Ad hoc news
News
Stories
Stories
All Stories
Company
Pharmacy & healthcare
Technology
Sustainability
People
Operations
Partners
Marketing
17 Apr 2024
Ad hoc News
DocMorris launches approx. CHF 200 million Convertible Bonds due 2029
Read more
17 Apr 2024
News
Simple, fast and secure: Redeem e-prescriptions directly with your health card at DocMorris now
Read more
16 Apr 2024
News
DocMorris continues to grow in the first quarter of 2024 and creates digital access to the entire e-prescription market
Read more
10 Apr 2024
Ad hoc News
DocMorris AG: DocMorris receives gematik approval for simple digital e-prescription redemption via health card
Read more
21 Mar 2024
Ad hoc News
DocMorris AG: Significant earnings improvement in 2023; e-prescription is standard in Germany
Read more
15 Feb 2024
News
TeleClinic and ADAC: Partnership expands access to digital healthcare
Read more
08 Feb 2024
Stories
People
Technology
Digital Pioneers: IT vocational training at DocMorris
Read more
01 Feb 2024
News
Dorit Posdorf takes over marketing at DocMorris Germany
Read more
31 Jan 2024
News
Change in the management of TeleClinic
Read more
22 Jan 2024
Stories
Technology
People
The finesse of finding errors - an insight into QA testing
Read more
16 Jan 2024
News
DocMorris achieves significant revenue growth in the fourth quarter of 2023 and confirms inflection point by increasing active customer base
Read more
15 Jan 2024
News
The Gesundbergs are arriving: DocMorris launches new e-prescription advertising campaign
Read more
05 Dec 2023
News
DocMorris and Klarna Team Up to Streamline Online Healthcare Shopping Experience in Germany
Read more
28 Nov 2023
Stories
People
Pharmacy & healthcare
Masters of precision: How our PTAs guarantee a safe supply of medicines
Read more
23 Nov 2023
Stories
Marketing
People
How marketing is shaping the Black Friday landscape
Read more
22 Nov 2023
Ad hoc News
DocMorris optimises organisational structure and prepares for e-prescription growth in Germany
Read more
31 Oct 2023
News
Reiner Kern takes over Communications and Public Affairs at DocMorris
Read more
19 Oct 2023
Ad hoc News
DocMorris strengthens path to profitable growth in third quarter; slightly reduced revenue outlook
Read more
11 Oct 2023
Stories
Pharmacy & healthcare
People
Between customer service, quality control and formulation
Read more
11 Oct 2023
Stories
Operations
People
The team behind the scenes: Customer Service
Read more
20 Sep 2023
News
DocMorris launches retail media offer with Criteo
Read more
29 Aug 2023
News
TeleClinic and DasLab Transforming Early Detection in Germany, Launch At-Home Colorectal Cancer Screening
Read more
17 Aug 2023
Ad hoc News
DocMorris: Solid basis for sustainable, profitable growth
Read more
06 Jul 2023
News
DocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions
Read more
26 May 2023
Ad hoc News
DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Read more
12 May 2023
Ad hoc News
DocMorris (formerly Zur Rose Group) announces a tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Read more
11 May 2023
News
New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
Read more
04 May 2023
News
Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)
Read more
04 May 2023
Ad hoc News
Zur Rose Group has successfully completed the sale of its Swiss business to Migros
Read more
20 Apr 2023
News
Zur Rose Group: Revenue in the first quarter 2023 in line with plan
Read more
12 Apr 2023
News
Zur Rose Group AG publishes invitation to the Annual General Meeting on 4 May 2023
Read more
23 Mar 2023
Ad hoc News
Zur Rose Group: Revenue and earnings targets for 2022 achieved; significant step towards profitability
Read more
03 Feb 2023
Ad hoc News
Zur Rose Group hands over successful Swiss business to Migros to focus on growth in Germany
Read more
03 Feb 2023
News
Zur Rose Switzerland to become part of Medbase Group
Read more
19 Jan 2023
Ad hoc News
Zur Rose Group: Revenue target 2022 achieved, EBITDA better than expected
Read more
24 Nov 2022
News
Zur Rose Group takes next step towards profitability and further reduces complexity in Germany
Read more
01 Nov 2022
Ad hoc News
Procurement and supply chain brought together under the new Chief Operations Officer
Read more
20 Oct 2022
Ad hoc News
Zur Rose Group announces results of Tender Offer
Read more
20 Oct 2022
News
After the first nine months, the Zur Rose Group is at the upper end of targets for revenue and EBITDA for 2022
Read more
07 Oct 2022
Ad hoc News
Zur Rose Group announces preliminary result and extension of Tender Offer
Read more
23 Sep 2022
Ad hoc News
Zur Rose Group announces a tender offer for all of its CHF 115 million outstanding bonds due 2023
Read more
13 Sep 2022
News
Final allocations of Zur Rose approx. CHF 95 million Convertible Bonds Offering
Read more
01 Sep 2022
Ad hoc News
Zur Rose Group successfully completes placement of approx. CHF 95 million Convertible Bonds and the approx. CHF 44 million Capital Increase by way of an accelerated book building process
Read more
31 Aug 2022
Ad hoc News
Zur Rose Group launches approx. CHF 100 million Convertible Bonds and approx. CHF 50 million Capital Increase by way of an accelerated book building process
Read more
18 Aug 2022
Ad hoc News
Zur Rose Group speeds up path to profitability and plans break-even at EBITDA level in 2023
Read more
22 Jun 2022
News
Tobias Leipold, CEO and Co-Founder, leaves eHealth-Tec GmbH
Read more
31 May 2022
News
Betül Susamis Unaran leaves Zur Rose Group
Read more
28 Apr 2022
News
Zur Rose Group AG: Shareholders approve all proposals
Read more
20 Apr 2022
News
Zur Rose Group sees revenue perform as expected in the first quarter of 2022
Read more
06 Apr 2022
Ad hoc News
Zur Rose Group AG publishes invitation to the Annual General Meeting of 28 April 2022
Read more
Load more
